Cargando…
Clinical manifestations in patients with PI*MM(Malton) genotypes. A matter still unsolved in alpha‐1 antitrypsin deficiency
We report the genetic variants associated with alpha‐1 antitrypsin deficiency (AATD) in 117 patients admitted to our outpatient clinic and characterized by a serum concentration of AAT lower than 113 mg/dL. We focused on the M‐like heterozygous variant of the SERPINA1 gene called PI*MM(Malton), and...
Autores principales: | Aiello, Marina, Fantin, Alberto, Longo, Chiara, Ferrarotti, Ilaria, Bertorelli, Giuseppina, Chetta, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029433/ https://www.ncbi.nlm.nih.gov/pubmed/32076552 http://dx.doi.org/10.1002/rcr2.528 |
Ejemplares similares
-
Clinical manifestations of a new alpha‐1 antitrypsin genetic variant:
Q0parma
por: Aiello, Marina, et al.
Publicado: (2022) -
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018) -
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
por: Bianchera, Annalisa, et al.
Publicado: (2023) -
Pulmonary hernia: Case report and review of the literature
por: Scelfo, Chiara, et al.
Publicado: (2018) -
New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)